Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
15.52
+0.92 (6.30%)
At close: Feb 6, 2026, 4:00 PM EST
15.00
-0.52 (-3.35%)
After-hours: Feb 6, 2026, 5:44 PM EST
Sutro Biopharma Market Cap
Sutro Biopharma has a market cap or net worth of $132.22 million as of February 6, 2026. Its market cap has decreased by -21.01% in one year.
Market Cap
132.22M
Enterprise Value
-17.71M
1-Year Change
-21.01%
Ranking
Category
Stock Price
$15.52
Market Cap Chart
Since September 27, 2018, Sutro Biopharma's market cap has decreased from $346.92M to $132.22M, a decrease of -61.89%. That is a compound annual growth rate of -12.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 132.22M | 34.14% |
| Dec 31, 2025 | 98.57M | -35.03% |
| Dec 31, 2024 | 151.72M | -41.98% |
| Dec 29, 2023 | 261.49M | -43.69% |
| Dec 30, 2022 | 464.40M | -32.55% |
| Dec 31, 2021 | 688.50M | -30.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Whitehawk Therapeutics | 136.67M |
| Black Diamond Therapeutics | 136.17M |
| Oramed Pharmaceuticals | 136.12M |
| Sangamo Therapeutics | 133.88M |
| Adagene | 133.85M |
| Fate Therapeutics | 132.66M |
| Connect Biopharma Holdings | 130.26M |
| Spero Therapeutics | 129.02M |